title: Targeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles.
authors.affiliation: Children's Center for Cancer & Blood Diseases, Children's Hospital Los Angeles (CHLA), Los Angeles, CA 90027, USA.
authors.forename: Fatih M
authors.initials: FM
authors.lastname: Uckun
authors.forename: Sanjive
authors.initials: S
authors.lastname: Qazi
authors.forename: Jianjun
authors.initials: J
authors.lastname: Cheng
mesh_terms: D000818:Animals; D001483:Base Sequence; D004337:Drug Carriers; D005091:Exons; D055785:Gene Knockdown Techniques; D006801:Humans; D053758:Nanoparticles / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000235:genetics; D012333:RNA, Messenger / Q000187:drug effects*; D034741:RNA, Small Interfering / Q000008:administration & dosage*; D017384:Sequence Deletion; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000235:genetics*; D013234:Stem Cells / Q000187:drug effects
chemical_list: D004337:Drug Carriers; D010455:Peptides; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D051918:Sialic Acid Binding Ig-like Lectin 2
keywords: CD19; biotherapy; cancer; health; leukemia; nanotechnology; personalized medicine